0001209191-21-041498.txt : 20210617
0001209191-21-041498.hdr.sgml : 20210617
20210617170054
ACCESSION NUMBER: 0001209191-21-041498
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210616
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Beck Joanne T.
CENTRAL INDEX KEY: 0001768045
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38722
FILM NUMBER: 211025539
MAIL ADDRESS:
STREET 1: C/O CATABASIS PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQ, BLD. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orchard Therapeutics plc
CENTRAL INDEX KEY: 0001748907
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 108 CANNON STREET
CITY: LONDON
STATE: X0
ZIP: EC4N 6EU
BUSINESS PHONE: 011-44-0-203-3846700
MAIL ADDRESS:
STREET 1: 108 CANNON STREET
CITY: LONDON
STATE: X0
ZIP: EC4N 6EU
FORMER COMPANY:
FORMER CONFORMED NAME: Orchard Rx Ltd
DATE OF NAME CHANGE: 20180802
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-16
0
0001748907
Orchard Therapeutics plc
ORTX
0001768045
Beck Joanne T.
C/O ORCHARD THERAPEUTICS PLC
108 CANNON STREET
LONDON
X0
EC4N 6EU
UNITED KINGDOM
1
0
0
0
Stock Option (Right to Buy)
4.79
2021-06-16
4
A
0
40000
0.00
A
2031-06-15
Ordinary Shares
40000
40000
D
All of the shares subject to this option vest upon the earlier to occur of June 16, 2022 or the date of the 2022 Annual General Meeting of the Company.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
/s/ Frank Thomas, as attorney-in-fact
2021-06-17